YU16303A - Tartaratne soli derivata tiazolidindiona - Google Patents

Tartaratne soli derivata tiazolidindiona

Info

Publication number
YU16303A
YU16303A YU16303A YUP16303A YU16303A YU 16303 A YU16303 A YU 16303A YU 16303 A YU16303 A YU 16303A YU P16303 A YUP16303 A YU P16303A YU 16303 A YU16303 A YU 16303A
Authority
YU
Yugoslavia
Prior art keywords
compound
thiazolidinedione derivative
tartarate salts
tartarate
salts
Prior art date
Application number
YU16303A
Other languages
English (en)
Inventor
Bernadette Marie Choudary
Andrew Simon Craig
Tim Chien Ting Ho
Donald Colin Mackenzie
Deirdre O'keeffe
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of YU16303A publication Critical patent/YU16303A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Novo farmaceutsko jedinjenje 5-[4-[2-(N-metil-N-(2-piridil)-amino)etoksi]-benzil]tiazolidin-2,4-dion D-(-)-tartaratili njegov solvat, postupak dobijanja ovog jedinjenja, farmaceutski preparat koji sadrži ovo jedinjenje i upotreba ovog jedinjenja u medicini.[A novel pharmaceutical compound 5-[4-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione D(-) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceuitcal composition comprising such a compound and the use of such a compound in medicine.
YU16303A 2000-08-04 2001-08-03 Tartaratne soli derivata tiazolidindiona YU16303A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019228.6A GB0019228D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
YU16303A true YU16303A (sh) 2006-01-16

Family

ID=9897030

Family Applications (1)

Application Number Title Priority Date Filing Date
YU16303A YU16303A (sh) 2000-08-04 2001-08-03 Tartaratne soli derivata tiazolidindiona

Country Status (36)

Country Link
US (1) US20040048899A1 (sh)
EP (1) EP1305312B1 (sh)
JP (1) JP2004505972A (sh)
KR (1) KR100755173B1 (sh)
CN (1) CN1458931A (sh)
AP (1) AP1814A (sh)
AT (1) ATE393153T1 (sh)
AU (1) AU2001276509A1 (sh)
BG (1) BG107606A (sh)
BR (1) BR0112981A (sh)
CA (1) CA2417829A1 (sh)
CZ (1) CZ2003316A3 (sh)
DE (1) DE60133746T2 (sh)
DK (1) DK1305312T3 (sh)
DZ (1) DZ3467A1 (sh)
EA (1) EA004764B1 (sh)
EC (1) ECSP034469A (sh)
ES (1) ES2302506T3 (sh)
GB (1) GB0019228D0 (sh)
HK (1) HK1057359A1 (sh)
HR (1) HRP20030070A2 (sh)
HU (1) HUP0300777A3 (sh)
IL (2) IL154278A0 (sh)
MA (1) MA25898A1 (sh)
MX (1) MXPA03001087A (sh)
NO (1) NO324595B1 (sh)
NZ (1) NZ524032A (sh)
OA (1) OA12352A (sh)
PL (1) PL360703A1 (sh)
PT (1) PT1305312E (sh)
SI (1) SI1305312T1 (sh)
SK (1) SK1442003A3 (sh)
UA (1) UA76721C2 (sh)
WO (1) WO2002012234A1 (sh)
YU (1) YU16303A (sh)
ZA (1) ZA200300963B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
AR047530A1 (es) * 2004-02-04 2006-01-25 Novartis Ag Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil)-benzamida
EA010307B1 (ru) * 2004-06-30 2008-08-29 Эли Лилли Энд Компани Фармацевтическое соединение
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
PL360703A1 (en) 2004-09-20
OA12352A (en) 2006-05-16
HUP0300777A3 (en) 2005-04-28
DZ3467A1 (fr) 2002-02-14
EA200300234A1 (ru) 2003-06-26
MA25898A1 (fr) 2003-10-01
UA76721C2 (uk) 2006-09-15
EA004764B1 (ru) 2004-08-26
NO20030507D0 (no) 2003-01-31
CN1458931A (zh) 2003-11-26
JP2004505972A (ja) 2004-02-26
HRP20030070A2 (en) 2005-02-28
WO2002012234A1 (en) 2002-02-14
MXPA03001087A (es) 2003-05-27
NO324595B1 (no) 2007-11-26
PT1305312E (pt) 2008-06-19
SK1442003A3 (en) 2004-05-04
DK1305312T3 (da) 2008-07-28
IL154278A (en) 2009-02-11
ATE393153T1 (de) 2008-05-15
DE60133746D1 (de) 2008-06-05
ES2302506T3 (es) 2008-07-16
ZA200300963B (en) 2004-04-19
CA2417829A1 (en) 2002-02-14
ECSP034469A (es) 2003-06-25
EP1305312B1 (en) 2008-04-23
DE60133746T2 (de) 2009-05-14
IL154278A0 (en) 2003-09-17
AP1814A (en) 2008-01-04
EP1305312A1 (en) 2003-05-02
BG107606A (bg) 2003-09-30
GB0019228D0 (en) 2000-09-27
NZ524032A (en) 2004-07-30
BR0112981A (pt) 2003-08-26
HUP0300777A2 (hu) 2003-11-28
AP2003002738A0 (en) 2003-03-31
KR100755173B1 (ko) 2007-09-03
CZ2003316A3 (en) 2004-03-17
KR20030022357A (ko) 2003-03-15
US20040048899A1 (en) 2004-03-11
HK1057359A1 (en) 2004-04-02
NO20030507L (no) 2003-03-26
SI1305312T1 (sl) 2008-08-31
AU2001276509A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
YU16303A (sh) Tartaratne soli derivata tiazolidindiona
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
WO2000063205A3 (en) Thiazolidinedione derivative and its use as antidiabetic
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
WO2003099337A3 (en) Inclusion complexes of rosiglitazone